ASXCASENSUS SURGICAL, INC.

NYSE asensus.com


$ 0.27 $ -0.01 (-1.82 %)    

Tuesday, 16-Apr-2024 14:33:58 EDT
QQQ $ 432.53 $ 1.51 (0.35 %)
DIA $ 378.92 $ -0.49 (-0.13 %)
SPY $ 505.34 $ 0.59 (0.12 %)
TLT $ 88.32 $ 0.21 (0.24 %)
GLD $ 221.56 $ 1.70 (0.77 %)
$ 0.275
$ 0.27
$ 0.26 x 1,000
$ 0.30 x 200
$ 0.26 - $ 0.27
$ 0.20 - $ 0.86
1,640,174
na
nm
$ 1.44
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 03-21-2024 12-31-2023 10-K
2 11-14-2023 09-30-2023 10-Q
3 08-10-2023 06-30-2023 10-Q
4 05-11-2023 03-31-2023 10-Q
5 03-02-2023 12-31-2022 10-K
6 11-10-2022 09-30-2022 10-Q
7 08-08-2022 06-30-2022 10-Q
8 05-04-2022 03-31-2022 10-Q
9 02-28-2022 12-31-2021 10-K
10 11-03-2021 09-30-2021 10-Q
11 08-05-2021 06-30-2021 10-Q
12 05-11-2021 03-31-2021 10-Q
13 03-11-2021 12-31-2020 10-K
14 11-05-2020 09-30-2020 10-Q
15 08-05-2020 06-30-2020 10-Q
16 05-15-2020 03-31-2020 10-Q
17 03-16-2020 12-31-2019 10-K
18 11-12-2019 09-30-2019 10-Q
19 08-08-2019 06-03-2019 10-Q
20 05-09-2019 03-31-2019 10-Q
21 02-27-2019 12-31-2018 10-K
22 11-08-2018 09-30-2018 10-Q
23 08-07-2018 06-30-2018 10-Q
24 05-08-2018 03-31-2018 10-Q
25 03-08-2018 12-31-2017 10-K
26 11-09-2017 09-30-2017 10-Q
27 08-02-2017 06-30-2017 10-Q
28 05-10-2017 03-31-2017 10-Q
29 03-06-2017 12-31-2016 10-K
30 11-09-2016 09-30-2016 10-Q
31 08-05-2016 06-30-2016 10-Q
32 05-10-2016 03-31-2016 10-Q
33 03-03-2016 12-31-2015 10-K
34 11-09-2015 09-30-2015 10-Q
35 08-06-2015 06-30-2015 10-Q
36 05-06-2015 03-31-2015 10-Q
37 02-20-2015 12-31-2014 10-K
38 11-07-2014 09-30-2014 10-Q
39 08-06-2014 06-30-2014 10-Q
40 05-08-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 wayfair-to-rally-over-28-here-are-10-top-analyst-forecasts-for-thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

 hc-wainwright--co-downgrades-asensus-surgical-to-neutral-lowers-price-target-to-035

HC Wainwright & Co. analyst Swayampakula Ramakanth downgrades Asensus Surgical (AMEX:ASXC) from Buy to Neutral and lower...

 hc-wainwright--co-maintains-buy-on-asensus-surgical-maintains-2-price-target

HC Wainwright & Co. analyst Swayampakula Ramakanth maintains Asensus Surgical (AMEX:ASXC) with a Buy and maintains $2 pr...

 asensus-surgical-q4-eps-007-beats-008-estimate-sales-543m-beat-530m-estimate

Asensus Surgical (AMEX:ASXC) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.08...

 earnings-scheduled-for-march-21-2024

Companies Reporting Before The Bell • Creative Realities (NASDAQ:CREX) is expected to report quarterly earnings at $0.02 per s...

 asensus-surgical-earnings-preview
Asensus Surgical Earnings Preview
03/20/2024 17:01:20

 asensus-surgical-fy23-unaudited-revenue-is-expected-to-be-approximately-82m-88m-versus-consensus-of-779m-and-q4-sales-of-51m-57m-versus-consensus-of-467m

2023 Full Year Highlights Over 3,550 procedures were performed globally, representing 14% growth compared to 2022 In 2023, ...

 cantor-fitzgerald-downgrades-asensus-surgical-to-neutral

Cantor Fitzgerald analyst Ross Osborn downgrades Asensus Surgical (AMEX:ASXC) from Overweight to Neutral.

 hc-wainwright--co-reiterates-buy-on-asensus-surgical-maintains-2-price-target

HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Asensus Surgical (AMEX:ASXC) with a Buy and maintains $2 p...

 earnings-scheduled-for-november-14-2023

Companies Reporting Before The Bell • CureVac (NASDAQ:CVAC) is likely to report quarterly loss at $0.24 per share on revenue o...

NEW CASE INVESTIGATION